COX-2 promotes metastasis and predicts prognosis in gastric cancer via regulating mTOR

被引:8
|
作者
Xiang, Liangliang [1 ,2 ]
Wang, Weimin [1 ,2 ,3 ]
Zhou, Zhen [1 ,2 ]
Lv, Mengying [1 ,2 ]
Tao, Li [1 ,2 ]
Ni, Tengyang [1 ,2 ]
Deng, Jianliang [3 ]
Masatara, Sunagawa [4 ]
Liu, Yanqing [1 ,2 ,3 ]
Zhou, Yan [1 ,2 ,3 ]
机构
[1] Yangzhou Univ, Inst Translat Med, Coll Med, Yangzhou 225001, Jiangsu, Peoples R China
[2] State Adm Tradit Chinese Med, Key Lab Syndrome Differentiat & Treatment Gastr C, Tradit Chinese Med Adm, Yangzhou 225001, Jiangsu, Peoples R China
[3] Yangzhou Univ, Dept Oncol, Yixing Hosp, Coll Med, Yixing 214200, Jiangsu, Peoples R China
[4] Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
COX-2; gastric cancer; metastasis; mTOR; prognosis; METABOLISM; TARGET; INFLAMMATION; CULLIN1; MARKER;
D O I
10.2217/bmm-2019-0357
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: Gastric cancer (GC) is one of the most common malignant tumors in the world. It is important to find accurate and reliable biomarkers in order to decrease whole morbidity and mortality. Results: We examined the expression of COX-2 and mTOR on GC tissue microarrays by immunohistochemistry. Multi-variate COX regression analysis showed that the expression of COX-2 or mTOR was an independent factor in the prognosis of GC patients. In addition, COX-2 and mTOR had the potentially synergistic effect on predicting the prognosis of GC. Conclusion: The combined expression of COX-2 and mTOR could serve as efficient prognostic indicators and COX-2 could suppress GC metastasis via regulating mTOR.
引用
收藏
页码:421 / 432
页数:12
相关论文
共 50 条
  • [1] FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
    Xi-Lu Hou
    Cheng-Dong Ji
    Jun Tang
    Yan-Xia Wang
    Dong-Fang Xiang
    Hai-Qing Li
    Wei-Wei Liu
    Jiao-Xue Wang
    He-Zhong Yan
    Yan Wang
    Peng Zhang
    You-Hong Cui
    Ji-Ming Wang
    Xiu-Wu Bian
    Wei Liu
    [J]. Scientific Reports, 7
  • [2] FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
    Hou, Xi-Lu
    Ji, Cheng-Dong
    Tang, Jun
    Wang, Yan-Xia
    Xiang, Dong-Fang
    Li, Hai-Qing
    Liu, Wei-Wei
    Wang, Jiao-Xue
    Yan, He-Zhong
    Wang, Yan
    Zhang, Peng
    Cui, You-Hong
    Wang, Ji-Ming
    Bian, Xiu-Wu
    Liu, Wei
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [3] The mechanism of COX-2 regulating HERG channel in gastric cancer cells
    Shao, X. D.
    Guo, X. Z.
    Ren, L. N.
    Lin, H.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (08): : 487 - 491
  • [4] The mechanism of COX-2 regulating HERG channel in gastric cancer cells
    Shao Xiao-Dong
    Guo Xiao-Zhong
    Ren Li-Nan
    Lin Hao
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 858 - 858
  • [5] α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer
    Zhan, Panpan
    Zhao, Shihu
    Yan, Hua
    Yin, Chunli
    Xiao, Yi
    Wang, Yunshan
    Ni, Ruoxuan
    Chen, Weiwen
    Wei, Guangwei
    Zhang, Pengju
    [J]. MOLECULAR CARCINOGENESIS, 2017, 56 (05) : 1427 - 1437
  • [6] TRAF6 promotes the invasion and metastasis and predicts a poor prognosis in gastric cancer
    Han, Fei
    Zhang, Long
    Qiu, Weizhe
    Yi, Xianghua
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (01) : 31 - 37
  • [7] COX-2 and angiogenesis in gastric cancer
    Walther, Z
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (01) : 4 - 6
  • [8] COX-2 Expression in Gastric Cancer
    Bekdemir, Handan
    Tekin, Salim B.
    Bilici, Mehmet
    Cayir, Kerim
    Gundogdu, Cemal
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2010, 20 (01): : 34 - 41
  • [9] COX-2 Inhibitors and Gastric Cancer
    Wang, Zhen
    Chen, Jun-qiang
    Liu, Jin-lu
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [10] Effect of NETs/COX-2 pathway on immune microenvironment and metastasis in gastric cancer
    Zhang, Ange
    Zou, Xiaoming
    Yang, Shifeng
    Yang, Hao
    Ma, Zhen
    Li, Jiacheng
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14